Description
Human Microbiome Drug Targets: Modern Approaches in Disease Management presents fundamental information on the human microbiome, looking into the relationship between the microbiome and how it changes with specific diseases. Delving into the multifaceted roles of the microbiome in health and disease, the book's chapters discuss the role of the human microbiome in the pathophysiologic understanding of relevant diseases or disorders and their management. As changes in the human microbiome can provide clues to the probable cause and effect of diseases or disorders, as well as the impacts of therapy or intervention, this book is a welcomed addition to the existing research. Explaining how a better understanding of the microbiome and its impact on health and disease can pave the way for future discoveries leading to better health outcomes, this book will be of interest to drug developers, medicinal chemists, microbiologists, infectious disease specialists, biochemists, and students.- Provides readers with background information on the human microbiome, its evolution, and current understanding- Includes chapters dedicated to the importance of the human microbiome as "drugs" and as drug targets- Serves as a guide to drug developers working in pharma, biotech, and academia, bringing together the latest research on the topic
Table of Contents
Part One: Foundational Information1. Tracing the History of Microbiome Evolution2. The Human Microbiome: An Overview3. The GUT Microbiome4. The Microbiome and One Health Approach5. Overview of Human Microbiome and Drug DiscoveryPart Two: Human Microbiome in Health and Disease6. Human Microbiome and Nutrition7. Human Microbiome and Mental Health8. Human Microbiome and Diabetes9. Human Microbiome and Cancer and Cancer Therapy10. Human Microbiome, Obesity and Cardiovascular Diseases11. Human Microbiome and Respiratory Diseases12. Human Microbiome and Liver Diseases13. Human Microbiome and Neuro-Developmental Disorders14. Human Microbiome and Inflammatory DiseasesPart Three: Microbiome and Drug Discovery15. The Human Microbiome as Drug Targets16. Microbiome-Based Therapeutics (Including Probiotics, Prebiotics and Symbiotics)17. Microbiome Metabolite Based Therapies18. Role of Nanotechnology in Microbiome Drug Development19. Microbiome-Based Therapies on Trial
